Lyrica (pregabalin) oral solution launched

An oral liquid formulation of Lyrica (pregabalin) is now available from Pfizer.

Pregabalin is a GABA analogue that binds to voltage-gated calcium channels in the central nervous system | SCIENCE PHOTO LIBRARY
Pregabalin is a GABA analogue that binds to voltage-gated calcium channels in the central nervous system | SCIENCE PHOTO LIBRARY

Originally licensed as an adjunctive therapy for partial seizures with or without secondary generalisation, the gamma-aminobutyric acid (GABA) analogue is also licensed for generalised anxiety disorder and for the treatment of peripheral and central neuropathic pain.

The oral solution contains 20mg pregabalin per ml. It is available in a 473ml bottle pack and also contains a graduated oral syringe with adaptor.

View Lyrica Oral Solution drug record

Further information: Pfizer

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases